IL17A and infection: In vivo, IL-17A and IL-6 are upregulated in early-stage MAP-infected lesions (Grade 1) (34), but not in late infection/clinical Johne's disease lesions, suggesting that Th17 responses to MAP are subject to the same T cell exhaustion that occurs with Th1-like cells in late clinical JD (35).